Core Viewpoint - Meili Tianyuan Medical Health (02373) is set to acquire 100% of Shanghai Siyuanli Industrial for 1.25 billion yuan (approximately 1.369 billion HKD), which is expected to enhance its market position and expand its store network significantly [1] Group 1: Acquisition Details - The acquisition of Shanghai Siyuanli Industrial will allow Meili Tianyuan to own the high-end skincare brand "Siyuanli" in China [1] - Post-acquisition, the number of stores is projected to reach 734, indicating rapid expansion [1] Group 2: Market Position and Growth Potential - Meili Tianyuan is recognized as a leading player in the domestic beauty and medical beauty service sector, with a strong brand reputation and operational capabilities [1] - The company is expected to see performance growth driven by deepening digital transformation, improved supply chain layout, and ongoing store expansion [1] Group 3: Analyst Insights - Huachuang Securities has issued a report projecting a compound annual growth rate for profits over the next three years, alongside a target price of 43.56 HKD, maintaining a "strong buy" rating [1]